Degree | Type | Year | Semester |
---|---|---|---|
2502445 Veterinary Medicine | OT | 5 | 2 |
It is advised to have passed the Pharmacology curriculum from 3rd year of studies.
The Main Objective is to convey the scientific criteria underlying medicines research that reassure on their use in clinical practice, with the goal of both optimize its therapeutic use in veterinary medicine, and, if the student aims at it, facilitate a professional futur within the pharmaceutical industry (human or veterinary)
The Specific Objectives are:
- that the student understand the scientific rationale behind the studies needed for medicines approval:quality, efficacy and safety (used in human and animals) 35%
- that the student incorporated the benefit-to-risc concept as a key paradigm in health sciences 10%
- that the student questions the recomendations for mediciens approval and holds the ability to debate and propose alternative approaches 25%
- that the student acquires knowledge on pharmaceutical companies corporate organization to undertake discovery, research and marketing of medicines 10%
- that the student understands that regulation is science that offers reassurance to patients 10%
- raise awareness for futur clinicians of the need of following up the therapeutic performance of marketed medicines (pharmacovigilance) 10%
Live teaching: 26 hours per student
- 22 hours interactive theoretical sessions
- 2 hours: projects presentation
- 2 hours: visit to pharmaceutical company
+ Student's project + individual/team supervised work
Syllabus
Medicines R+D put into context
- Objectives of the course and sessions dynamics
- Brainstorming: R+D rationale
- Healthcare authroties role: regulation is science
- Recap: R+D steps
Setting up the project
- Projects setup
- Teams set up: subject per team
- Explanation of project execution
Discovery phase
- sources of identification and information of new molecules
Preclinical studies (1): objective and design
- Objectives of preclinical studies.
- Efficacy studies:Target identification and validation. Biological and in silico systems
Preclinical studies (2): toxicity
- Safety pre-assessmnt: Characterization of toxicity.
- NOAEL. Genotoxicity, Immunotoxicicty, etc
Production and formulation of medicines + quality control (1)
- Medicines manufacturing: chemically synthesized and biologics.
- Phases: active substance characterization.
- Formulation
Production and formulation of medicines + quality control (2)
Projects presentation - Debate
- Presentation : teams
- Feed back
- Assessment
Clinical studies: Objectives
- Objectives of clinical research - Design rationale
- Phase I (First-in-human): PK, safety and tolerability
- Objectives and execution
Patient studies
Innovators – Biosimilars etc
Veterinary medicines development
Biopharmaceutical industry
Overview
Projects exhibition
Annotation: Within the schedule set by the centre or degree programme, 15 minutes of one class will be reserved for students to evaluate their lecturers and their courses or modules through questionnaires.
Title | Hours | ECTS | Learning Outcomes |
---|---|---|---|
Type: Directed | |||
Field sessions | 2 | 0.08 | 4, 6 |
Theoretical sessions | 22 | 0.88 | 1, 4, 5, 6, 7, 9, 10, 3, 12, 11, 14 |
Type: Supervised | |||
Tutorials | 10 | 0.4 | 1, 4, 5, 6, 7, 9, 10, 3, 12, 11, 14 |
Work execution and search of information | 16 | 0.64 | 1, 13, 4, 5, 6, 7, 9, 10, 3, 12, 11 |
Type: Autonomous | |||
Case-studies and problem solving | 24.5 | 0.98 | 1, 13, 4, 5, 6, 7, 9, 10, 3, 12, 11, 14 |
Team work: • The student will demonstrate the skills acquired throughout the course program by presenting a work that will be supervised. • Individual or team work. • Attendance at the seminar sessions and visits to the industry and the work discussion sessions will be mandatory, forming part of the student's evaluation process.
Title | Weighting | Hours | ECTS | Learning Outcomes |
---|---|---|---|---|
Assessment of Knowledge (exam) | 30% | 0.5 | 0.02 | 1, 13, 2, 4, 5, 6, 7, 9, 10, 3, 12, 11, 8, 14 |
Involvement-participation | 20% | 0 | 0 | 1, 13, 2, 4, 5, 6, 7, 9, 10, 3, 12, 11, 14 |
Project discussion | 50% | 0 | 0 | 1, 13, 4, 5, 6, 10, 12, 11, 8 |
Se entregará a principio de curso.
No software is used